Sort   by:  
 Page size 
An unbiased quantitative phosphoproteomics analysis in 16HBE cells treated with or without IL-13 and 2-D08.
ORGANISM(S): Homo Sapiens 
2023-06-08 | PXD042842 |
Epidermal growth factor receptor (EGFR) mutations are leading oncogenic drivers in non-small cell lung cancer (NSCLC). Many third-generation EGFR tyrosine kinase inhibitors (TKIs) have been developed to target EGFR T790M and activating mutations. Osimertinib (AZD9291) was the first approved drug and...
ORGANISM(S): Homo Sapiens 
2023-07-14 | PXD043776 |
Sort   by:  
 Page size